Follow
Prof. Dr.Bijo Mathew (M.Pharm (Chem)., Ph.D.)
Prof. Dr.Bijo Mathew (M.Pharm (Chem)., Ph.D.)
Professor of Pharmaceutical Chemistry,Amrita School of Pharmacy,Amrita Vishwa Vidyapeetham
Verified email at aims.amrita.edu - Homepage
Title
Cited by
Cited by
Year
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
N Zahin, R Anwar, D Tewari, M Kabir, A Sajid, B Mathew, M Uddin, ...
Environmental Science and Pollution Research 27 (16), 19151-19168, 2020
1432020
Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool
J Jose, R Kumar, S Harilal, GE Mathew, DGT Parambi, A Prabhu, M Uddin, ...
Environmental Science and Pollution Research 27 (16), 19214-19225, 2020
972020
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
MS Uddin, A Al Mamun, M Jakaria, S Thangapandiyan, J Ahmad, ...
Science of the Total Environment 707, 135624, 2020
852020
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
S Harilal, J Jose, DGT Parambi, R Kumar, GE Mathew, MS Uddin, H Kim, ...
Journal of Pharmacy and Pharmacology 71 (9), 1370-1383, 2019
852019
Combination drug therapy for the management of Alzheimer’s disease
MT Kabir, MS Uddin, AA Mamun, P Jeandet, L Aleya, RA Mansouri, ...
International journal of molecular sciences 21 (9), 3272, 2020
842020
Melatonin in Alzheimer’s disease: a latent endogenous regulator of neurogenesis to mitigate Alzheimer’s neuropathology
M Hossain, M Uddin, GM Uddin, DM Sumsuzzman, M Islam, GE Barreto, ...
Molecular Neurobiology 56 (12), 8255-8276, 2019
842019
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
B Mathew, DGT Parambi, GE Mathew, MS Uddin, ST Inasu, H Kim, ...
Archiv der Pharmazie 352 (11), 1900177, 2019
822019
Cholinesterase inhibitors for Alzheimer's disease: multitargeting strategy based on anti-Alzheimer's drugs repositioning
MT Kabir, M Uddin, M Begum, S Thangapandiyan, M Rahman, L Aleya, ...
Current Pharmaceutical Design 25 (33), 3519-3535, 2019
822019
Toxic tau: structural origins of tau aggregation in Alzheimer's disease
A Al Mamun, MS Uddin, B Mathew, GM Ashraf
Neural Regeneration Research 15 (8), 1417, 2020
802020
Nootropic and anti-Alzheimer’s actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer’s neuropathology
M Uddin, A Al Mamun, M Kabir, M Jakaria, B Mathew, GE Barreto, ...
Molecular neurobiology 56 (7), 4925-4944, 2019
762019
Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies
B Mathew, GE Mathew, G Uçar, I Baysal, J Suresh, JK Vilapurathu, ...
Bioorganic Chemistry 62, 22-29, 2015
762015
Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors
B Mathew, A Haridas, G Uçar, I Baysal, AA Adeniyi, MES Soliman, M Joy, ...
International journal of biological macromolecules 91, 680-695, 2016
672016
Molecular insight into the therapeutic promise of flavonoids against Alzheimer’s disease
MS Uddin, MT Kabir, K Niaz, P Jeandet, C Clément, B Mathew, A Rauf, ...
Molecules 25 (6), 1267, 2020
662020
NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer's therapy
MT Kabir, MA Sufian, M Uddin, M Begum, S Akhter, A Islam, B Mathew, ...
Current Pharmaceutical Design 25 (33), 3506-3518, 2019
642019
Heteroaryl chalcones: Mini review about their therapeutic voyage
B Mathew, J Suresh, S Anbazghagan, J Paulraj, GK Krishnan
Biomedicine & Preventive Nutrition 4 (3), 451-458, 2014
642014
Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors
R Sasidharan, SL Manju, G Uçar, I Baysal, B Mathew
Archiv der Pharmazie 349 (8), 627-637, 2016
632016
Estrogen signaling in Alzheimer’s disease: molecular insights and therapeutic targets for Alzheimer’s dementia
M Uddin, M Rahman, M Jakaria, M Hossain, A Islam, M Ahmed, B Mathew, ...
Molecular Neurobiology 57 (6), 2654-2670, 2020
562020
Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO‐B Inhibitors
B Mathew, A Haridas, G Uçar, I Baysal, M Joy, GE Mathew, ...
ChemMedChem 11 (11), 1161-1171, 2016
552016
Monoamine oxidase inhibitory action of chalcones: a mini review
B Mathew, A Haridas, J Suresh, G E Mathew, G Uçar, V Jayaprakash
Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2016
542016
Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease
MS Uddin, MT Kabir, D Tewari, B Mathew, L Aleya
Science of the Total Environment 700, 134836, 2020
522020
The system can't perform the operation now. Try again later.
Articles 1–20